Business ❯Finance ❯Bankruptcy ❯Corporate Restructuring

WeightWatchers

WeightWatchers Files for Bankruptcy as GLP-1 Weight-Loss Drugs Reshape Industry

The company plans to reorganize $1.15 billion in debt while competitors and telehealth firms pivot to capitalize on the booming GLP-1 drug market.

WeightWatchers Files for Chapter 11 Bankruptcy to Restructure $1.15 Billion Debt

WeightWatchers Files for Chapter 11 Bankruptcy to Restructure $1.15 Billion Debt

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

WeightWatchers Prepares for Bankruptcy as Weight Loss Drug Demand Surges